IJCRR - Vol 05 Issue 11, June, 2013
DEXMEDETOMIDINE AND BUPRENORPHINE AS ADJUVANT TO SPINAL ANAESTHESIA - A COMPARATIVE STUDY
Author: B. Maharani, M. Sathya Prakash, Paramesh Kalaiah, N.C. Elango
Background: Dexmedetomidine – an α2 agonist, Buprenorphine – an opioid receptor agonist and antagonist can be safely used as adjuvants to spinal anaesthesia. There are no studies comparing dexmedetomidine and buprenorphine when used as adjuvants in subarachnoid block. Aim: The objectives of the study: To evaluate and compare the onset and duration of sensory and motor block, perioperative analgesia, side effect profile of dexmedetomidine and buprenorphine when used as adjuvant to bupivacaine in spinal anaesthesia for surgeries below the level of umbilicus. Materials and methods: Sixty patients of ASA I & II scheduled for lower abdominal & lower limb surgeries were randomly allocated in to two groups (group A & group B) and received the following drugs ? Group A – 15 mg of 0.5% Hyperbaric bupivacaine + 10 μg of Dexmedetomidine ? Group B – 15 mg of 0.5% Hyperbaric bupivacaine + 60 μg of Buprenorphine. Sensory and motor blockade characteristics (onset time, time to reach maximum level and regression), time for rescue analgesia and side effects were recorded. Observed parameters were statistically analyzed by using independent sample ‘t’ test (SPSS version 12). P<0.05 was considered statistically significant. Results: Addition of dexmedetomidine as adjuvant to bupivacaine had significantly shortened the onset of sensory blockade (100.50±31.74 and 122.13±36.25, P<0.05), prolonged the duration of motor and sensory block (P<0.001, P<0.001 respectively) and had postponed the time for first analgesic request (295.83±93.21 and 238.27±110.36, P<0.05) without any side effects when compared to buprenorphine (P<0.05, P<0.001). Conclusion: 10μg of dexmedetomidine seems to be a better alternative to 60 μg of buprenorphine when added as adjuvant to bupivacaine in spinal block for lower abdominal and lower limb surgeries below the level of umbilicus.
Keywords: Dexmedetomidine, Buprenorphine, Bupivacaine, Lower abdominal surgery.
B. Maharani, M. Sathya Prakash, Paramesh Kalaiah, N.C. Elango. DEXMEDETOMIDINE AND BUPRENORPHINE AS ADJUVANT TO SPINAL ANAESTHESIA - A COMPARATIVE STUDY International Journal of Current Research and Review. Vol 05 Issue 11, June, 104-110
1. Fischer HBJ. Regional anaesthesia and analgesia. In: Pinnock CA, Rowbotham D, Parr SM, Lin D, Appadu BL, Fischer HBJ. Fundamentals of Anaesthesia. London: Greenwich medical media limited; 1999. pp. 240.
2. Alahuhta S, Kangas-Saarela T, Hollmén AI, Edström HH. Visceral pain during caesarean section under spinal and epidural anaesthesia with bupivacaine. Acta Anaesthesiol Scand. 1990; 34: 95–8.
3. Buvanendran A, Kroin JS. Useful adjuvants for postoperative pain management. Best Pract Res Clin Anaesthesiol 2007; 21: 31– 49.
4. Agarwal K, Agarwal N, Agrawal V, Agrawal A, Sharma M, Agarwal K. Comparative analgesic efficacy of buprenorphine or clonidine with bupivacaine in the caesarean section. Indian Journal of Anaesthesia 2010; 54: 453-7.
5. Gadsden J, Hart S, Santos AC. Post cesarean delivery analgesia. Anaesth Anal 2005; 101: 62-9.
6. Panzer O, Moitra V, Sladen RN. Pharmacology of sedative analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anaesthetics, and the role of peripheral µ (mu) antagonists. Crit Care Clin 2009; 25: 451-69.
7. Kanazi GE, Aquad MT, Jabbour-Khoury SI, Aljazzar MD, Alameddine MM, AlYaman R et.al. Effect of low dosedexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiologica Scandinavica 2006; 50: 222-7.
8. Hala EA, Eid MD, Mohamed A, Shafie MD, Hend Youseef MD. Dose related prolongation of hyperbaric bupivacaine spinal anaesthesia by dexmedetomidine. Ain Shams Journal of Anaesthesiol 2011; 4: 83-95.
9. Al-Ghanem SM, Massad IM, Al-Mustafa MM, Al-Zaben KR, Qudaisat IY, Qatawneh AM et al. Effect of adding dexmedetomidine versus fentanyl to intrathecal bupivacaine on spinal block characteristics in gynecological procedures. Am J Appl sci 2009; 6: 882-7
10. Dixit S. Postoperative analgesia after caesarean section: an experience with intrathecal buprenorphine. Indian J Anaesth 2007; 51: 515-8
11. Gupta R, Bogra J, Verma R, Kohli M, Kushwaha JK, Kumar S. Dexmedetomidine as an intrathecal adjuvant for postoperative analgesia. Indian J Anaesth 2011; 55: 347- 51
12. Eisanach JC, De Kock M, Klimscha W. α- 2 adrenergic agonists for regional anesthesia. Anesthesiology 1996; 85: 655- 74.
13. Lawhead RG, Blaxall HS, Bylund BD. Alpha-2A is the predominant α-2 adrenergic receptor subtype in human spinal cord. Anesthesiology 1992;77: 983- 91.
14. Smith MS, Schumbra UB, Wilson KH et al. Alpha 2 adrenergic receptor in human spinal cord: specific localized expression of mRNA encoding alpha-2 adrenergic receptor subtypes at four distinct levels. Brain Res 1995; 34: 109-17.
15. Yaksh TL, Jage J, Takano Y. Pharmacokinetics and Pharmacodynamics of medullar agents. The spinal actions of α - 2 adrenergic agonists as analgesics. In: Atikenhead AR, Benad G, Brown BR, et al. Baillieres Clinical Anaesthesiology, Vol. 7, No. 3. London: Bailliere Tindall; 1993.pp. 597-614.
16. Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD. Tizanidine treatment of spasticity caused by multiple sclerosis. Neurology 1994; 44 (9): 34-43.
17. Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth 2011; 55: 352-7
18. Hall JE, Uhrich TD, Barney JA, Shahbaz RA, Ebert TJ. Sedative, amnestic and analgesic properties of small dose dexmedetomidine infusions. Anaesth Analg 2000; 90: 699-705
19. Aanta RE, Kanto JH, Scheinin M, Kallio A, Scheinin H. Dexmedetomidine, an α2- adrenoreceptor agonist, reduces anaesthetic requirement for patients undergoing minor gynaecological surgery. Anaesthesiology 1990; 73: 230-5
20. Fauzia A. Khan, Gauhar A. Hamdani. Comparison of Intrathecal Fentanyl and Buprenorphine in Urological Surgery. JPMA 2006; 56(6): 277-82